Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|June 2, 2025
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast CancerFatima Cardoso, Susanne Parke, Donal J Brennan, et al.
Maturitas|July 31, 2026
Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial programJoAnn V Pinkerton, James A Simon, Nick Panay, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 6, 2020
Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptomsAndrea Genazzani, Nick Panay, Tommaso Simoncini, et al.
Archives of Women'S Mental Health|January 8, 2013
Clinical subtypes of core premenstrual disorders: a Delphi surveyKhaled M K Ismail, Tracy Nevatte, Shaughn O'Brien, et al.
Menopause (New York, N.Y.)|April 2, 2024
Design of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopauseJoAnn V Pinkerton, James Simon, Nick Panay, et al.
European Heart Journal|January 26, 2021
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologistsAngela H E M Maas, Giuseppe Rosano, Renata Cifkova, et al.
JAMA|August 22, 2024
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical TrialsJoAnn V Pinkerton, James A Simon, Hadine Joffe, et al.
Climacteric : the Journal of the International Menopause Society|January 7, 2026
Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women's midlife healthAlison Maunder, Amelia K Mardon, Vibhuti Rao, et al.
JAMA Internal Medicine|September 8, 2025
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical TrialNick Panay, Hadine Joffe, Pauline M Maki, et al.
Climacteric : the Journal of the International Menopause Society|December 8, 2024
Evidence-based guideline: premature ovarian insufficiency†‡, Nick Panay, Richard A Anderson, et al.
Pageof 10